We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patient Advocacy Groups Call for More Requirements in Biosimilar Labeling Guidance
Patient Advocacy Groups Call for More Requirements in Biosimilar Labeling Guidance
In stark contrast to comments from generic industry trade groups, a patient advocacy organization is calling for including more information in biosimilar product labeling.